WINDWARD BIO GROUP AG (WWB) company profile
WWBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$22.64−3.12 (-12.11%)
Close on Nov 18, 2026Market cap –P/E –Yield –
About Windward Bio
Biological Products, (No Diagnostic Substances), SIC 2836
WINDWARD BIO GROUP AG is listed on Nasdaq under the ticker WWB, in the SEC industry Biological Products, (No Diagnostic Substances). It is incorporated in V8 and its fiscal year ends on December 31.
Company profile
Company
- Legal name
- WINDWARD BIO GROUP AG
- Industry
- Biological Products, (No Diagnostic Substances)
- Incorporated in
- V8
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- WWB
- Exchange
- Nasdaq
- SEC CIK
- 2145089
- FIGI
- BBG0268LL8F2
- Share class FIGI
- BBG0268LL9F0
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Luca Santarelli | Chief Executive Officer, Director | 4,578,110 |
| Scott Applebaum | Chief Legal & Corp Dev Officer | 960,966 |
| Claudia D'Augusta | Chief Financial Officer | 927,760 |
| Kevin Andrew Harris | Chief Operating Officer | 960,966 |
| Omar Khwaja | Chief Medical Officer | 642,136 |
| Advisors Llc Orbimed | Director | 7,097,483 |
| Capital GP IX LLC OrbiMed | Director | – |
| Otello Stampacchia | Director | 5,338,520 |
| David P. Bonita | Director | 7,097,483 |
| Iqbal Rasool Mufti | Director | – |
| Sandip Kapadia | Director | 100,000 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Nov 9, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?